<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 1 TO
FORM 10-QSB/A
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For Quarter Ended June 30, 1996 -- Commission File Number 000-21930
BIOSOURCE INTERNATIONAL, INC.
(Exact name of Small Business Issuer as specified in its charter)
DELAWARE 77-0340829
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
820 FLYNN ROAD, CAMARILLO, CALIFORNIA 93012
(Address of principal executive offices) (Zip Code)
Issuer's telephone number, including area code: (805) 987-0086
None
- -------------------------------------------------------------------------------
(Former name, former address, and former fiscal year if changed
since last report)
Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act during the past 12 months
(or for such shorter period that the issuer was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes X No ___
Number of common shares of issuer
outstanding at September 9, 1996 8,312,195
<PAGE> 2
PART II -- OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
On July 1, 1996 the Proposals below were submitted to a vote of security
holders at the Annual Meeting of the Shareholders of BioSource International,
Inc. The Annual Meeting of Shareholders was adjourned to July 31, 1996 and
again adjourned to August 30, 1996 for the purpose of addressing open
Proposal 2. and Proposal 4. outlined below.
Proposal 1. To authorize certain actions to effect the delisting of the
Company from the Vancouver Stock Exchange:
FOR AGAINST ABSTAIN NON-VOTES
4,866,129 12,171 25,672 449,442
Proposal 2. To amend the Company's Certificate of Incorporation to establish
a classified Board of Directors and limit certain stockholder actions:
FOR AGAINST ABSTAIN NON-VOTES
2,824,269 294,052 198,346 2,278,803
Proposal 3. The election of the following persons to serve as directors of
BioSource International, Inc., a Delaware corporation, until the next regular
Annual Meeting of the Shareholders of BioSource International, Inc. and
until their successors have been duly elected and qualified:
FOR AGAINST ABSTAIN NON-VOTES
James H. Chamberlain 5,300,523 0 52,891 0
Leonard M. Hendrickson 5,300,623 0 52,791 0
David S. Moffa, Ph.D. 5,294,568 0 58,846 0
Robert D. Weist 5,294,923 0 58,491 0
John R. Overturf, Jr. 5,292,723 0 60,691 0
Proposal 4. To amend the Company's 1993 Stock Incentive Plan:
FOR AGAINST ABSTAIN NON-VOTES
2,975,122 246,104 95,441 2,278,803
Proposal 5. To ratify the appointment of KPMG Peat Marwick LLP as the
Company's independent public accountants for the year ending December 31, 1996:
FOR AGAINST ABSTAIN NON-VOTES
5,302,040 20,928 30,446 0
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BIOSOURCE INTERNATIONAL, INC.
By: Anna Anderson
---------------------------
September 9, 1996 Anna Anderson
Vice President and
Chief Financial Officer
James H. Chamberlain
---------------------------
September 9, 1996 James H. Chamberlain
President and Chief
Executive Officer
